Sean Arlauckas

Sean Arlauckas

Harvard University - Cambridge / United States
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 1392669
person_outline Sean Arlauckas's MOST POPULAR ARTICLES
1-) TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapyCB Rodell, SP Arlauckas, MF Cuccarese, CS Garris, R Li, MS Ahmed, ...Nature biomedical engineering 2 (8), 578-588, 20185752018
2-) Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-γ and IL-12CS Garris, SP Arlauckas, RH Kohler, MP Trefny, S Garren, C Piot, ...Immunity 49 (6), 1148-1161. e7, 20185282018
3-) In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapySP Arlauckas, CS Garris, RH Kohler, M Kitaoka, MF Cuccarese, KS Yang, ...Science translational medicine 9 (389), eaal3604, 20174532017
4-) IRF3 and type I interferons fuel a fatal response to myocardial infarctionKR King, AD Aguirre, YX Ye, Y Sun, JD Roh, RP Ng Jr, RH Kohler, ...Nature medicine 23 (12), 1481-1487, 20174952017
5-) Arg1 expression defines immunosuppressive subsets of tumor-associated macrophagesSP Arlauckas, SB Garren, CS Garris, RH Kohler, J Oh, MJ Pittet, ...Theranostics 8 (21), 5842, 20182882018